Knight Announces Closing of Previously Announced Acquisition
26 May 2021 //
GLOBENEWSWIRE
Knight Therapeutics to Acquire Regional Rights to Exelon®
23 Apr 2021 //
GLOBENEWSWIRE
Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™
01 Mar 2021 //
GLOBENEWSWIRE
Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA®
21 Sep 2020 //
BUSINESSWIRE
Knight Therapeutics Announces Filling of Supplement for NERLYNX (neratinib)
03 Sep 2020 //
GLOBENEWSWIRE
Knight and TherapeuticsMD Announce Health Canada Approval of IMVEXXY®
25 Aug 2020 //
BUSINESSWIRE
Health Canada to review Knight`s NDS for Bijuva
28 Nov 2019 //
SEEKING ALPHA